Gomekli is the second ever FDA-approved treatment for rare tumor disease, NF1-PN and the first to be approved for both adult ...
ICON, which builds homes using 3D printing, has closed on $56 million in Series C funding co-led by Norwest Venture Partners ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback